Increased phosphorylation of HexM improves lysosomal uptake and potential for managing GM2 gangliosidoses
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in BBA Advances
- Vol. 2, 100032
Abstract
No abstract availableKeywords
Funding Information
- Canadian Glycomics Network
- Canadian Institutes of Health Research (PJT-162414)
This publication has 39 references indexed in Scilit:
- Simple piggyBac transposon-based mammalian cell expression system for inducible protein productionProceedings of the National Academy of Sciences, 2013
- Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophyHuman Molecular Genetics, 2011
- Strategy for effective brain drug deliveryEuropean Journal of Pharmaceutical Sciences, 2010
- Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological DisordersDevelopmental Neuroscience, 2009
- The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously ReportedPediatrics, 2006
- Crystallographic Structure of Human β-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of GM2 Ganglioside HydrolysisJournal of Molecular Biology, 2006
- Pharmacological Enhancement of β-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff PatientsJournal of Biological Chemistry, 2004
- Insulin‐like growth factor‐II/mannose‐6‐phosphate receptor: Widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotypeJournal of Comparative Neurology, 2003
- Direct Determination of the Substrate Specificity of the α-Active Site in Heterodimeric β-Hexosaminidase ABiochemistry, 1996
- Purification and Characterization of an Activator Protein for the Degradation of Glycolipids GM2and GA2by Hexosaminidase AHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1979